Angina Pectoris notes according to the medicine lecture 20 mark question notes, medicine lecture with the clinical features, etiology, investigation, diagnosis, management, and with definition.

Reading File

Finding Sources

Reading File

I have extensive content from Harrison's (the premier medicine textbook) and Goldman-Cecil. Let me now read more of Harrison's for the full clinical picture including investigations, diagnosis, and management.

Reading File

I have comprehensive content. I now have enough from Harrison's and Goldman-Cecil to compile a thorough 20-mark medicine lecture-style answer. Let me synthesize all the retrieved content.

Angina Pectoris — Medicine Lecture Notes (20 Marks)

1. DEFINITION

Angina pectoris is an episodic clinical syndrome of chest discomfort resulting from transient myocardial ischemia, produced when myocardial oxygen demand exceeds myocardial oxygen supply, without resulting in myocardial necrosis. The discomfort is typically described as heaviness, pressure, squeezing, smothering, or choking — only rarely as outright pain.

Harrison's Principles of Internal Medicine 22E, p. 2136

2. ETIOLOGY

Primary Cause

Coronary artery disease (CAD) / Atherosclerosis — the most common cause; obstructive or stenotic coronary artery disease reduces oxygen delivery.

Other Cardiovascular Causes

Coronary artery spasm (Prinzmetal/Variant angina)
Microvascular dysfunction (Cardiac Syndrome X)
Mural thrombosis at an atherosclerotic plaque
Severe aortic stenosis or aortic regurgitation
Hypertrophic obstructive cardiomyopathy (HOCM)
Uncontrolled hypertension (increased wall stress)
Severe anemia (reduced oxygen-carrying capacity)

Extracardiac Precipitants

Fever, thyrotoxicosis (increased metabolic demand)
Severe anemia, hypoxemia
Hypertension
Obesity, metabolic syndrome, type 2 diabetes

Pathogenetic Mechanisms

Mechanism	Description
Demand angina	Increased myocardial O₂ demand (exertion, emotion, stress) in the setting of fixed coronary stenosis
Supply angina	Reduced O₂ delivery — vasospasm, thrombosis, microvascular disease

Goldman-Cecil Medicine, block7; Harrison's, p. 2136

3. CLINICAL FEATURES

Symptoms

Classic presentation:

Chest discomfort — central, substernal; described as heaviness, pressure, squeezing, smothering, tightness — rarely sharp pain
Levine's sign — patient places a clenched fist over the sternum
Duration — typically 2–5 minutes, crescendo-decrescendo pattern
Radiation — to shoulders, arms (especially ulnar aspect of forearm and hand), neck, jaw, teeth, back, interscapular region, epigastrium
Rarely localizes below the umbilicus or above the mandible
Does not radiate to trapezius (more typical of pericarditis)

Precipitating factors:

Physical exertion (climbing stairs, walking briskly, sexual activity)
Emotional stress, anger, frustration, fright
Cold exposure
Heavy meals
Morning peak of symptoms

Relieving factors:

Rest (within 1–5 minutes)
Sublingual nitroglycerin (within 1–5 minutes)

Special Patterns

Pattern	Description
Stable (exertional) angina	Fixed threshold; reproducibly provoked by a predictable level of effort; relieved by rest
Unstable angina	New onset, crescendo angina, or rest angina; worsening frequency/severity
Variant (Prinzmetal) angina	Occurs at rest, caused by coronary vasospasm; ST elevation on ECG during attack
Angina decubitus	Occurs lying down; due to increase in end-diastolic volume, wall tension, and O₂ demand
Nocturnal angina	Awakens patient from sleep; related to episodic tachycardia or recumbent hemodynamic changes
Microvascular (Syndrome X)	Angina with normal coronary arteries; microvascular dysfunction

Atypical Presentations

More common in women, elderly, and diabetics
May present as dyspnea, fatigue, or epigastric discomfort only

Physical Examination

Often normal between episodes
During an attack: transient S₄ gallop, paradoxical splitting of S₂, mitral regurgitation murmur (papillary muscle dysfunction), precordial bulge
Signs of atherosclerosis: xanthelasma, arcus senilis, carotid bruits, absent peripheral pulses
Signs of risk factors: hypertension, obesity

Harrison's, pp. 2136–2138; Goldman-Cecil Medicine, block7

4. INVESTIGATIONS

Routine Blood Tests

Test	Purpose
CBC	Detect anemia (aggravates angina)
Fasting blood glucose / HbA1c	Diagnose/exclude diabetes
Lipid profile (total cholesterol, LDL, HDL, TG)	Identify dyslipidemia — key risk factor
Thyroid function tests	Rule out thyrotoxicosis
Renal function	Baseline before medications
Cardiac enzymes (Troponin I/T)	Exclude ACS/MI — normal in stable angina
CRP / hsCRP	Inflammatory marker; prognostic value

Electrocardiogram (ECG)

Resting ECG — often normal in stable angina; may show LVH, ST changes, Q waves (old MI), LBBB
ECG during an attack — ST depression (demand ischemia), T-wave inversion
Variant angina — ST elevation during episode (vasospasm)

Stress Testing

Test	Indication
Exercise ECG (Treadmill test)	Standard first-line; positive if ≥1 mm horizontal/down-sloping ST depression
Stress echocardiography	Better sensitivity/specificity; detects wall motion abnormalities; preferred when resting ECG abnormal
Nuclear stress test (SPECT/PET)	Myocardial perfusion imaging; detects ischemia and viability
Pharmacological stress test (dobutamine, adenosine)	For patients unable to exercise

Imaging

Test	Purpose
Chest X-ray	Assess heart size, pulmonary congestion, aortic calcification
Echocardiogram (resting)	LV function (EF), wall motion, valve disease, LVH
CT Coronary Angiography (CTCA)	Non-invasive; rules out significant CAD; calcium scoring
Coronary Angiography (Cardiac Cath)	Gold standard — defines anatomy, stenosis severity; required before revascularization
MRI / CMR	Viability assessment, microvascular disease

Harrison's, pp. 2138–2143; Goldman-Cecil Medicine, block7

5. DIAGNOSIS

Diagnostic Criteria

Angina pectoris is primarily a clinical diagnosis based on history. The three classic features (Diamond-Forrester classification):

Type	Criteria Met
Typical (definite) angina	All 3: substernal chest discomfort + provoked by exertion/stress + relieved by rest or nitrates
Atypical angina	2 of 3 features
Non-cardiac chest pain	0–1 features

CCS Grading Scale (Canadian Cardiovascular Society)

Class	Description
I	Angina only with strenuous or prolonged exertion; ordinary activity does not cause angina
II	Slight limitation of ordinary activity; angina on walking >2 blocks, climbing >1 flight of stairs
III	Marked limitation of ordinary activity; angina on walking 1–2 blocks or climbing 1 flight
IV	Inability to perform any activity without angina; angina may be present at rest

Differential Diagnosis

Cardiovascular: ACS, pericarditis, aortic dissection
Pulmonary: Pulmonary embolism, pleuritis, pneumothorax
GI: GERD, esophageal spasm (can closely mimic angina), peptic ulcer, biliary colic
Musculoskeletal: Costochondritis, chest wall pain (reproducible by palpation — argues against angina)
Other: Anxiety/panic attack, herpes zoster

Harrison's, pp. 2136–2138

6. MANAGEMENT

A. General Measures / Risk Factor Modification

Smoking cessation — accelerates atherosclerosis, increases thrombotic risk, reduces O₂ supply; most important modifiable risk factor
Weight reduction — achieves optimal BMI; reduces associated DM, HTN, dyslipidemia
Dietary modification — low saturated/trans fat, low calorie, Mediterranean diet
Regular aerobic exercise — improves coronary collateral circulation; cardiac rehabilitation
Strict glycemic control in diabetics
Blood pressure control (target <130/80 mmHg)
Lipid management — statins are cornerstone (target LDL reduction)
Avoid precipitating factors — heavy meals, cold, emotional stress

B. Pharmacological Management

1. Anti-Anginal Drugs

Drug Class	Mechanism	Examples	Notes
Nitrates (sublingual)	Venodilation → reduced preload; coronary vasodilation	GTN (nitroglycerin)	For acute attack; onset 1–3 min; give at rest, seated
Nitrates (long-acting)	Sustained venodilation	Isosorbide mononitrate/dinitrate	Prophylaxis; nitrate-free interval (8h) to avoid tolerance
Beta-blockers	Reduce heart rate & contractility → ↓ O₂ demand; first-line	Metoprolol, Atenolol, Bisoprolol	Cardioselective preferred; avoid in vasospastic angina; target HR 55–60 bpm
Calcium Channel Blockers (CCBs)	Vasodilation + ↓ heart rate/contractility	Amlodipine (DHP); Diltiazem, Verapamil (non-DHP)	DHP for exertional angina; non-DHP avoid with beta-blockers (bradycardia risk); drug of choice in Prinzmetal angina
Ranolazine	Inhibits late INa → ↓ intracellular Ca²⁺ overload	Ranolazine	Add-on therapy; no hemodynamic effects; useful in patients intolerant to beta-blockers
Ivabradine	Selective If channel inhibitor → ↓ HR	Ivabradine	For patients in sinus rhythm intolerant to beta-blockers

2. Antiplatelet Therapy (Cardioprotective)

Aspirin 75–150 mg daily — first-line antiplatelet; reduces risk of MI and death in stable CAD
Clopidogrel — alternative if aspirin contraindicated; also post-PCI

3. Statins (HMG-CoA Reductase Inhibitors)

All CAD patients regardless of baseline LDL — plaque stabilization + lipid lowering
Examples: Atorvastatin 40–80 mg, Rosuvastatin 20–40 mg (high-intensity therapy)

4. ACE Inhibitors / ARBs

Indicated in patients with concurrent heart failure, LV dysfunction, diabetes, or hypertension
Examples: Ramipril, Perindopril, Lisinopril

5. Management of Acute Attack

Patient sits or lies down
Sublingual GTN (glyceryl trinitrate) 0.3–0.5 mg; may repeat every 5 min × 3 doses
If no relief after 15 min → call emergency (suspect ACS/NSTEMI)

C. Revascularization

1. Percutaneous Coronary Intervention (PCI)

Coronary angioplasty ± stent (drug-eluting stent preferred)
Indicated for significant single or multivessel disease, failed medical therapy
Choice for focal stenosis; good for symptoms relief

2. Coronary Artery Bypass Grafting (CABG)

Indicated for:
- Left main coronary artery disease (>50% stenosis)
- Triple vessel disease (especially with reduced EF)
- Diabetics with multivessel disease
- Failed PCI
Superior to PCI for survival benefit in complex multivessel CAD and LV dysfunction

Harrison's, pp. 2139–2148; Goldman-Cecil Medicine, block7

7. SUMMARY TABLE

Aspect	Key Points
Definition	Transient myocardial ischemia → chest discomfort; supply-demand mismatch
Most common cause	Atherosclerotic CAD
Classic symptom	Substernal pressure/heaviness, 2–5 min, provoked by exertion, relieved by rest/GTN
Radiation	Left arm (ulnar), jaw, neck, back; never trapezius
Levine's sign	Clenched fist over sternum
Gold standard investigation	Coronary angiography
First-line anti-anginal	Beta-blocker (with aspirin + statin)
Acute attack drug	Sublingual GTN
Prinzmetal angina drug	Calcium channel blocker
Revascularization	PCI (single/double vessel); CABG (left main, triple vessel, diabetics)
CCS Class IV	Angina at rest — unstable; urgent intervention needed

Sources:

Harrison's Principles of Internal Medicine 22E (2025, McGraw Hill Medical), Chapter 284
Goldman-Cecil Medicine International Edition, Chapter 39

Can you combine the notes from Davidson, Harrison, and Golwalla book and compile it and make a proper notes of angina pectoris and give it to me?

Finding Sources

Davidson's and Golwalla's are not in the library. However, I have Harrison's, Goldman-Cecil, Braunwald's Heart Disease, and Fuster & Hurst's The Heart — which are all equally authoritative standard medicine textbooks used in medical education. Let me read deeply from all available sources to give the best combined notes.

Finding Sources

Reading File

I now have very rich content from Harrison's and Goldman-Cecil. Let me get the Braunwald/Katzung pharmacology and Robbins pathology sections for additional detail on pathophysiology and drugs.

Reading File

Note: Davidson's Principles & Practice of Internal Medicine and Golwalla's Medicine for Students are not available in the digital library. However, the notes below are compiled from four other premier standard textbooks — Harrison's Principles of Internal Medicine 22E, Goldman-Cecil Medicine, Robbins Pathologic Basis of Disease, and Katzung's Basic & Clinical Pharmacology — which together cover the same content as Davidson's and Golwalla's (and in several areas go deeper). The notes are organized in the exact lecture format expected for a 20-mark medicine question.

ANGINA PECTORIS

Combined Notes — Harrison's | Goldman-Cecil | Robbins | Katzung

1. DEFINITION

Angina pectoris is an episodic clinical syndrome of paroxysmal, recurrent substernal or precordial chest discomfort caused by transient myocardial ischemia — a mismatch between myocardial oxygen demand and myocardial oxygen supply — that is insufficient to cause myocyte necrosis (i.e., no infarction occurs).

The word "angina" derives from the Latin for "strangling" or "choking." The discomfort is described as heaviness, pressure, squeezing, smothering, or tightness — only rarely as frank pain.

Harrison's 22E, Ch. 284 | Robbins Pathologic Basis of Disease, Ch. 12

2. EPIDEMIOLOGY

Males constitute ~70% of all patients with angina pectoris, and a higher proportion of those aged <50 years
Nearly 10 million people in the USA have angina pectoris
Among adults aged 60–79 years: 25% of men and 16% of women have coronary heart disease
Cardiovascular disease is the leading cause of death globally — ~18 million deaths/year (32% of all deaths)

Goldman-Cecil Medicine, Ch. 56

3. ETIOLOGY

Primary Cause

Coronary artery disease (CAD) / Atherosclerosis — the most common cause; fixed obstructive plaques reduce coronary perfusion

Cardiac Non-Atherosclerotic Causes

Cause	Mechanism
Coronary artery spasm	Vasospasm → reduced supply (Prinzmetal angina)
Coronary arteritis	Inflammatory narrowing
Hypertrophic obstructive cardiomyopathy (HOCM)	Outflow obstruction + microvascular compression
Severe aortic stenosis / Aortic regurgitation	Reduced coronary perfusion pressure
Microvascular dysfunction (Syndrome X)	Abnormal microvascular reactivity with normal epicardial arteries
Myocardial bridging	Systolic compression of coronary artery
Dilated cardiomyopathy	Elevated LVEDP → subendocardial ischemia

Non-Cardiac Causes (Precipitants)

Cause	Mechanism
Severe anaemia / Sickle cell disease	Reduced O₂-carrying capacity
Thyrotoxicosis	Increased myocardial O₂ demand
Hypertension	Increased wall stress, LVH
Hypoxaemia / Carbon monoxide poisoning	Reduced O₂ delivery
Polycythaemia	Hyperviscosity → reduced flow
Pheochromocytoma	Catecholamine surge → demand↑
Obesity, Diabetes mellitus, Dyslipidaemia	Accelerated atherosclerosis

Goldman-Cecil Medicine, Table 56-2 | Robbins, Ch. 12

4. PATHOPHYSIOLOGY

The Core Concept: Supply–Demand Mismatch

Angina results whenever myocardial oxygen demand exceeds supply. Ischemia rapidly follows — ischemia-induced release of adenosine, bradykinin, and substance P stimulates sympathetic and vagal afferent nerve fibres, generating the sensation of angina.

Two Major Mechanisms

Mechanism	Description	Example
Demand angina	Increased myocardial O₂ requirements in the setting of fixed stenosis	Exertional angina, emotional stress
Supply angina	Reduced O₂ delivery — vasospasm, thrombosis, or microvascular disease	Prinzmetal (variant) angina

Determinants of Myocardial O₂ Demand

Heart rate — most important (↑HR = shorter diastole = less perfusion time)
Wall stress (Laplace's Law: proportional to pressure × radius / wall thickness)
Contractility (inotropy)

Why Ischemia Causes Symptoms

Ischemia → anaerobic metabolism → lactate accumulation → acidosis
Adenosine and bradykinin activate sympathetic afferents → perceived as chest discomfort
Silent ischemia occurs (especially in elderly and diabetics with autonomic neuropathy) when this pathway is blunted — patient may present only with dyspnea, fatigue, or arrhythmia

Harrison's 22E, Ch. 284 | Robbins, Ch. 12 | Goldman-Cecil, Ch. 56

5. CLASSIFICATION / TYPES OF ANGINA

Type	Description	Precipitant	ECG During Attack
Stable (Typical) Angina	Most common; fixed atherosclerotic stenosis; reproducible threshold	Exertion, emotion, cold, heavy meal	ST depression (horizontal/down-sloping)
Unstable Angina	New onset, crescendo, or rest angina; plaque disruption + thrombus; harbinger of MI	Progressive — occurs at rest	ST depression or T-wave inversion
Prinzmetal (Variant) Angina	Coronary vasospasm; unrelated to exertion; responds to vasodilators	Rest, often at night/early morning	ST elevation (transient)
Microvascular Angina (Syndrome X)	Normal coronary arteries; microvascular dysfunction	Exertion	ST depression or normal
Angina Decubitus	Occurs lying down; due to increased LVEDV → ↑ wall tension	Recumbency	ST changes
Nocturnal Angina	Wakes patient from sleep; episodic tachycardia or respiratory changes during sleep	Sleep	Variable
Mixed Angina	Features of both stable and vasospastic angina	Variable	Variable

Robbins Pathologic Basis of Disease, Ch. 12

6. CLINICAL FEATURES

6a. Symptoms

Typical patient: Man >50 years or woman >60 years

Character of discomfort:

Central, substernal chest discomfort
Quality: heaviness, pressure, squeezing, smothering, tightness, choking; rarely sharp
Levine's sign — patient places a clenched fist over the sternum (pathognomonic gesture)
Crescendo-decrescendo pattern (not at maximal intensity at onset)
Duration: 2–5 minutes (stable angina); >20 min suggests ACS/MI

Radiation:

Left shoulder and arm (ulnar aspect of forearm and hand) — most classic
Both arms/shoulders
Neck, jaw, teeth
Back, interscapular region
Epigastrium
❌ Does not radiate to the trapezius (that pattern = pericarditis)
❌ Rarely below the umbilicus or above the mandible

Precipitating factors:

Physical exertion (climbing stairs, hurrying, sexual activity)
Emotional stress (anger, fright, frustration)
Cold weather
Heavy meal (post-prandial)
Morning hours (circadian increase in sympathetic tone)

Relieving factors:

Rest — typically within 1–5 minutes
Sublingual GTN (nitroglycerin) — within 1–3 minutes
⚠ If not relieved by rest + nitrates after 15 minutes → suspect ACS

Associated symptoms:

Dyspnea (due to transient LV dysfunction during ischemia)
Diaphoresis (sweating)
Nausea
Palpitations
Fatigue (particularly in women and elderly)

Atypical presentations (more common in women, elderly, diabetics):

Epigastric pain mimicking indigestion
Isolated dyspnea or fatigue
Nausea, vomiting, or diaphoresis without chest pain
Silent ischemia — no symptoms at all (common in diabetics with autonomic neuropathy and the elderly)

6b. Physical Examination

Between episodes — often NORMAL

During or after an episode:

S₄ gallop (atrial gallop) — transient, due to reduced LV compliance during ischemia
S₃ gallop — if LV dysfunction develops
Transient mitral regurgitation murmur (papillary muscle ischemia)
Paradoxical splitting of S₂ (LBBB during ischemia)
Transient precordial bulge (dyskinetic segment)
Signs of elevated filling pressures: basal crepitations

Signs of associated conditions / risk factors:

Corneal arcus, xanthelasma, xanthomata (dyslipidaemia)
Retinal arteriolar changes (hypertension, diabetes)
Elevated BP (hypertension)
Carotid bruits, absent peripheral pulses (generalised atherosclerosis)
Signs of heart failure (raised JVP, peripheral oedema)
Obesity, central adiposity

Harrison's 22E, p. 2136–2138 | Goldman-Cecil, Ch. 56

7. CCS GRADING OF ANGINA PECTORIS

(Canadian Cardiovascular Society Classification)

Class	Description
Class I	Angina only with strenuous or prolonged exertion; ordinary physical activity (walking, climbing stairs) does not cause angina
Class II	Slight limitation of ordinary activity; angina on walking >2 blocks on the level or climbing >1 flight of stairs at a normal pace
Class III	Marked limitation of ordinary activity; angina on walking 1–2 blocks or climbing 1 flight of stairs
Class IV	Inability to perform any physical activity without angina; angina may be present at rest

Goldman-Cecil Medicine, Ch. 39 | Harrison's 22E, Table 284-1

8. INVESTIGATIONS

8a. Blood Tests

Investigation	Purpose
Full Blood Count (CBC)	Detect anaemia (aggravates angina)
Fasting Blood Glucose / HbA1c	Diagnose/exclude diabetes mellitus
Lipid Profile (TC, LDL, HDL, TG)	Identify dyslipidaemia — major risk factor
Thyroid Function Tests (TSH, T₃, T₄)	Exclude thyrotoxicosis
Serum Urea, Creatinine, Electrolytes	Baseline renal function before medications
Cardiac Enzymes (Troponin I/T)	Normal in stable angina — elevated in ACS/NSTEMI/STEMI
CRP / hsCRP	Inflammatory marker; prognostic significance
LFTs	Baseline before statin therapy

8b. Electrocardiogram (ECG)

Timing	Findings
Resting ECG (between attacks)	Often normal in stable angina; may show LVH, T-wave changes, Q waves (old MI), LBBB
During an attack — Stable/Unstable angina	ST depression (horizontal or down-sloping ≥1 mm), T-wave inversion — demand ischemia
During Prinzmetal (Variant) angina	ST elevation (transient, resolves with nitrate)
After an attack	T-wave normalises

8c. Stress Testing (Exercise Tolerance Test / ETT)

Standard treadmill ECG (ETT) — First-line investigation; positive if ≥1 mm horizontal or down-sloping ST depression at any stage
Stress Echocardiography — Better sensitivity/specificity; detects segmental wall motion abnormalities; preferred when resting ECG is abnormal (LBBB, LVH)
Nuclear Perfusion Imaging (SPECT/PET) — Myocardial perfusion imaging; identifies ischemic vs. viable vs. infarcted myocardium
Pharmacological Stress Testing (Dobutamine, Adenosine, Dipyridamole) — For patients unable to exercise

8d. Imaging

Investigation	Purpose
Chest X-ray (CXR)	Heart size, pulmonary congestion, aortic calcification, cardiomegaly
Echocardiogram (2D Echo)	LV systolic function (EF), regional wall motion, valve disease, LVH, pericardial effusion
CT Coronary Angiography (CTCA)	Non-invasive; coronary anatomy; calcium scoring; high negative predictive value to exclude CAD
Coronary Angiography (Cardiac Catheterisation)	Gold standard — defines anatomy, localises and quantifies stenosis; essential before revascularisation
Cardiac MRI (CMR)	Viability assessment, microvascular obstruction, cardiomyopathy
Ambulatory (Holter) ECG Monitoring	Detects silent ischemia and arrhythmias

Harrison's 22E, p. 2138–2143 | Goldman-Cecil, Ch. 56

9. DIAGNOSIS

Clinical Diagnostic Criteria (Diamond-Forrester)

Type	Criteria
Typical (Definite) Angina	All 3: (i) Substernal chest discomfort + (ii) provoked by exertion/stress + (iii) relieved by rest or sublingual nitrates
Atypical Angina	Any 2 of 3 features above
Non-Cardiac Chest Pain	0–1 of the 3 features

Features That ARGUE AGAINST Angina (Goldman-Cecil)

Pain reproduced by movement or palpation of the chest wall
Pleuritic chest pain (sharp, worsened by breathing)
Sharp or constant pain lasting many hours
Pain localisable to chest wall with the tip of one finger
Very brief episodes lasting seconds

Differential Diagnosis

System	Conditions
Cardiovascular	ACS (NSTEMI/STEMI), Pericarditis, Aortic dissection, Myocarditis
Pulmonary	Pulmonary embolism, Pleuritis, Pneumothorax, Pneumonia
Gastrointestinal	GERD, Oesophageal spasm (may respond to nitrates!), Peptic ulcer, Biliary colic, Pancreatitis
Musculoskeletal	Costochondritis (Tietze syndrome), Chest wall pain
Neurological	Herpes zoster (pre-rash), Intercostal neuralgia
Psychiatric	Anxiety/Panic attack, Hyperventilation syndrome

Harrison's 22E, Ch. 15 | Goldman-Cecil, Ch. 56

10. MANAGEMENT

Management has three pillars: (A) General measures & risk factor modification, (B) Pharmacological therapy, (C) Revascularisation.

A. General Measures & Lifestyle Modification

Education and Reassurance — explain the nature of the condition
Smoking cessation — most important modifiable risk factor; accelerates atherosclerosis, increases thrombosis and plaque instability, worsens angina by reducing O₂ supply
Weight reduction — target BMI <25 kg/m²; obesity worsens HTN, DM, dyslipidaemia
Dietary modification — Mediterranean diet; low saturated fat and trans-fatty acids; low calorie
Regular aerobic exercise — cardiac rehabilitation; exercise below ischemic threshold (≤80% of heart rate at which ischemia occurs on ETT)
Strict glycaemic control in diabetics (target HbA1c ~7%)
Blood pressure control (target <130/80 mmHg)
Avoidance of precipitating factors — cold weather, heavy meals, emotional stress
Alcohol moderation

B. Pharmacological Management

1. Management of the Acute Anginal Attack

Patient should sit or lie down immediately
Administer Sublingual GTN (Glyceryl Trinitrate) 0.3–0.5 mg tablet or spray
May repeat every 5 minutes up to 3 doses
If no relief after 15 minutes → Emergency (suspect ACS) — call ambulance

2. Anti-Anginal Drugs (Prophylaxis)

Drug Class	Examples	Mechanism	Key Points
Beta-Blockers (First-line)	Metoprolol, Atenolol, Bisoprolol, Propranolol	Block β₁-adrenoceptors → ↓ HR, ↓ contractility, ↓ BP → ↓ myocardial O₂ demand	Cardioselective β₁ blockers preferred; target resting HR 55–60 bpm; avoid in vasospastic/Prinzmetal angina (worsen spasm); contraindicated in severe asthma, AV block
Long-acting Nitrates	Isosorbide mononitrate (ISMN), Isosorbide dinitrate (ISDN), Transdermal GTN patch	Release nitric oxide → ↑ cGMP → venodilation (↓ preload) + coronary vasodilation	Prophylaxis; nitrate-free interval of 8–12 h/day to prevent tolerance; headache and postural hypotension common side effects
Calcium Channel Blockers (CCBs)	Amlodipine, Nifedipine (DHP); Diltiazem, Verapamil (non-DHP)	Block L-type Ca²⁺ channels → coronary and peripheral vasodilation ± ↓ HR	Drug of choice for Prinzmetal/vasospastic angina; DHP (amlodipine) best for exertional angina; non-DHP (verapamil, diltiazem) — avoid combining with beta-blockers (risk of severe bradycardia/AV block)
Ranolazine	Ranolazine	Inhibits late sodium current (late INa) → ↓ intracellular Ca²⁺ → ↓ diastolic wall tension	Add-on therapy; no effect on HR or BP; useful when beta-blockers/CCBs are not tolerated or insufficient
Ivabradine	Ivabradine	Selective If channel inhibitor (SA node) → ↓ HR only	For sinus rhythm patients intolerant of beta-blockers; no effect on BP or contractility
Nicorandil	Nicorandil	K⁺-ATP channel opener + nitrate-like → ↓ pre & afterload	Second-line add-on; reduces angina frequency
Trimetazidine	Trimetazidine	Metabolic agent — shifts myocardial metabolism from fatty acid to glucose oxidation (more O₂-efficient)	Add-on; particularly in elderly and diabetics

3. Disease-Modifying / Cardioprotective Drugs

Drug	Indication	Notes
Aspirin 75–100 mg/day	All patients with CAD	Irreversible COX-1 inhibitor → ↓ TXA₂ → antiplatelet; reduces MI and CV death
Clopidogrel 75 mg/day	If aspirin contraindicated; also post-PCI/ACS	ADP-receptor antagonist (P2Y₁₂)
High-intensity Statin	All CAD patients (regardless of baseline LDL)	Plaque stabilisation + lipid lowering; Atorvastatin 40–80 mg or Rosuvastatin 20–40 mg
ACE Inhibitor / ARB	Concurrent heart failure, LV dysfunction (EF <40%), diabetes, hypertension	Ramipril, Perindopril, Lisinopril; proven mortality benefit in CAD

Katzung's Pharmacology 16E, Ch. 12 | Harrison's 22E, pp. 2139–2148 | Goldman-Cecil, Ch. 39

C. Revascularisation

Indicated when symptoms persist despite optimal medical therapy, or when anatomy/prognosis mandates intervention.

1. Percutaneous Coronary Intervention (PCI)

Balloon angioplasty ± Drug-Eluting Stent (DES) insertion
Preferred for single or double vessel disease, focal stenosis, failed medical therapy
Also primary treatment for STEMI
Dual antiplatelet therapy (DAPT) required post-PCI (aspirin + clopidogrel or ticagrelor)

2. Coronary Artery Bypass Grafting (CABG)

Surgical anastomosis using LIMA (Left Internal Mammary Artery) to LAD + saphenous vein grafts
Indications:
- Left main coronary artery disease (≥50% stenosis)
- Triple vessel disease, especially with reduced LV ejection fraction
- Diabetics with multivessel disease — CABG superior to PCI (FREEDOM trial)
- Failed/not suitable for PCI
- Concurrent cardiac surgery (valve replacement)
CABG provides superior survival benefit vs. PCI in complex multivessel disease and LV dysfunction

11. PROGNOSIS & COMPLICATIONS

Adverse Outcomes if Untreated / Poorly Controlled

Acute MI (Myocardial Infarction) — plaque rupture + complete thrombotic occlusion
Unstable Angina / NSTEMI — partial occlusion
Heart Failure — recurrent ischemia → hibernating/stunned myocardium → LV dysfunction
Arrhythmias — ventricular tachycardia, ventricular fibrillation
Sudden Cardiac Death

Factors Indicating Poor Prognosis

Low exercise tolerance on ETT (ischemia at low workload <5 METs)
ST depression ≥2 mm at low heart rate
Impaired LV systolic function (EF <40%)
Extensive perfusion defect on nuclear imaging
Left main or proximal LAD stenosis
Diabetes, hypertension, heart failure

12. QUICK REVISION SUMMARY

Aspect	Key Point
Definition	Transient myocardial ischemia; supply-demand mismatch; no necrosis
Most common cause	Atherosclerotic CAD
Characteristic symptom	Substernal heaviness/pressure, 2–5 min, exertional, → radiation to left arm/jaw
Levine's sign	Clenched fist over sternum
Relieved by	Rest (1–5 min) + Sublingual GTN
Drug of choice — acute attack	Sublingual GTN
First-line prophylaxis	Beta-blocker
Drug of choice — Prinzmetal angina	Calcium channel blocker (not beta-blockers!)
Cardioprotective drugs	Aspirin + Statin + ACE inhibitor
Gold standard investigation	Coronary angiography
First-line non-invasive test	Exercise ECG (Treadmill test)
ECG in stable angina attack	ST depression (horizontal/down-sloping)
ECG in Prinzmetal angina	Transient ST elevation
CABG preferred over PCI	Left main, triple vessel, diabetics with multivessel disease
CCS Class IV	Angina at rest — requires urgent intervention
Silent ischemia	Common in elderly, diabetics (autonomic neuropathy)

Sources:

Harrison's Principles of Internal Medicine 22E (2025), Chapters 15 & 284
Goldman-Cecil Medicine International Edition, Chapters 39 & 56
Robbins, Cotran & Kumar — Pathologic Basis of Disease, Chapter 12
Katzung's Basic & Clinical Pharmacology 16E, Chapter 12

⚠️ Davidson's Principles & Practice of Internal Medicine and Golwalla's Medicine for Students are not available in the digital library. The notes above cover all the same topics from equivalent-level standard textbooks used in undergraduate and postgraduate medicine curricula.These are your full combined Angina Pectoris notes. Here's a quick overview of what's covered:

Definition — Transient ischemia without necrosis; supply-demand mismatch
Epidemiology — Prevalence, sex differences, global burden
Etiology — Atherosclerosis as primary cause; full table of cardiac and non-cardiac causes
Pathophysiology — Demand vs. supply angina; role of adenosine/bradykinin; determinants of O₂ demand
Classification — Stable, Unstable, Prinzmetal, Microvascular, Decubitus, Nocturnal
Clinical Features — Levine's sign, character, radiation, precipitants, relieving factors, atypical presentations, physical exam findings
CCS Grading — Classes I–IV with descriptions
Investigations — Blood tests, ECG (resting + during attack + Prinzmetal), stress testing, imaging including gold standard (coronary angiography)
Diagnosis — Diamond-Forrester criteria, features against angina, differential diagnosis
Management — General measures, acute attack (sublingual GTN), anti-anginal drugs (beta-blockers, nitrates, CCBs, ranolazine, ivabradine), cardioprotective drugs (aspirin, statins, ACE-I), revascularisation (PCI vs. CABG)
Prognosis & Complications — MI, heart failure, arrhythmias, sudden death
Quick Revision Summary Table — All high-yield points at a glance

Tell me more about the types of angina, including the small-small symptoms.

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.